A Population-Based Study of Daily Nonsteroidal Anti-inflammatory Drug Use and Prostate Cancer
- 1 March 2002
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 77 (3) , 219-225
- https://doi.org/10.4065/77.3.219
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timingBritish Journal of Cancer, 1999
- Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteinsJournal of Endocrinology, 1999
- Use of Nonsteroidal Anti-inflammatory Drugs and Incidence of Colorectal CancerArchives of internal medicine (1960), 1999
- Evaluation of biomarker modulation by fenretinide in prostate cancer patients.European Urology, 1999
- Chemoprevention of prostate cancer: The prostate cancer prevention trialThe Prostate, 1997
- Phase II Chemoprevention Trial of Oral Fenretinide in Patients at Risk for Adenocarcinoma of the ProstateAmerican Journal of Clinical Oncology, 1997
- Familial Patterns of Prostate Cancer: A Case-Control AnalysisJournal of Urology, 1991
- Geographic pathology of latent prostatic carcinomaInternational Journal of Cancer, 1982
- Descriptive epidemiology of testicular and prostatic cancer in Los AngelesBritish Journal of Cancer, 1979